 |
 |
 |
 |
 |
Statins Reverse Doxorubicin Resistance in Mesothelioma Cells
Statins reverse doxorubicin resistance in human malignant mesothelioma cells in culture ...more |
|
 |
83 Year Old Man Dies from Mesothelioma Days After Winning Compensation
AN employee of a former ice cream factory has died of an asbestos-related disease ...more |
|
 |
New Research Findings
New Research Findings Published In National Academy Of Sciences Journal ...more |
|
 |
Air quality agency collects record asbestos fines
The Bay Area Air Quality Management District has collected $430,000 in asbestos fines ...more |
Professor from Loyola joins isle cancer center
Dr. Michele Carbone, lead investigator for two National Cancer Institute grants ...more |
CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for Mesothelioma
Announced today the initiation of patient dosing in a Phase II clinical trial evaluating the activity of PXD101 ...more |
Actor Paul Gleason dies from Mesothelioma
'The Breakfast Club' actor Paul Gleason dies at 67 ...more |
|
|
This website is licensed to the Law Office of _______________ ("The Firm"). Please understand that reading the information on this website does not mean that you have received legal or medical advice from The Firm. Sending The Firm electronic mail does not mean you have established an attorney-client relationship with The Firm. We cannot guarantee that the information found on this website is entirely correct, complete, or up-to-date. We therefore recommend that before you act on any of the information contained on this website, you first seek the direct advice of an attorney (if it is a legal matter) and/or a medical health professional (if it is a medical matter.) We believe that hiring an attorney and filing a lawsuit are serious matters, and are certainly too important to be based purely on what you read on this or any other website. If you have a question about our practice or are interested in having The Firm represent you, we invite you to contact The Firm. This website contains hyperlinks to other websites and publications. These links and references are there for your convenience; they do not mean that The Firm vouches for their accuracy or that The Firm is associated with them. Email can be sent to youremail@youremail.com; the Firm reminds you that email is not necessarily a secure or confidential form of communication. If you are concerned about this, send The Firm a letter by regular mail or telephone The Firm at (800) 555-1212.
|
|
|
|